Anti‐obesity effect of Actiponin supplementation in obese Korean subjects: A 12 week, randomized, double‐blind, placebo‐controlled clinical trial

@article{Park2011AntiobesityEO,
  title={Anti‐obesity effect of Actiponin supplementation in obese Korean subjects: A 12 week, randomized, double‐blind, placebo‐controlled clinical trial},
  author={Soo-Hyun Park and Hyangim Back and Sun-Young Kim and Eun-Ok Park and Mi-Ra Oh and Min-Gul Kim and Eun‐Kyung Choi and Su-Jin Jung and Il Han Yu and Hye-Mi Kim and T.-L. Huh and Youn-Soo Cha and Soo-Wan Chae},
  journal={The FASEB Journal},
  year={2011},
  volume={25}
}
To investigate the effects of Actiponin, a modified extract of Gynostemma pentaphyllum plant, on anti‐obesity effect in human, we carried out 12 week, randomized, double‐blind, placebo‐controlled clinical trial for obese Korean subjects.